Unbiased Analysis of Today's Healthcare Issues
Tomorrow I will be presenting a poster on “How well do surrogate endpoints and overall survival endpoints in clinical trials predict real-world survival?”at the American Society of Clinical Oncology (ASCO) conference. Below is the poster information if anyone wants to stop by. You can download the poster HERE. Session Title: Poster Session: Health Services Research and Quality…
One of my paper (along with co-authors Darius Lakdawalla, Claudio Lucarelli, Sean Nicholson, Zeba M. Khan and Tomas J. Philipson) was published at Health Affairs. The title of the study is: Quality-Adjusted Cost Of Care: A Meaningful Way To Measure Growth In Innovation Cost Versus The Value Of Health Gains. The abstract is below. Technology drives both…
The moving story of Paul Kalanithi. That message is simple: When you come to one of the many moments in life when you must give an account of yourself, provide a ledger of what you have been, and done, and meant to the world, do not, I pray, discount that you filled a dying man’s…
In his State of the Union, the President said that he was looking for additional funds for precision medicine. What would these funds be used for and how much money are we talking about? The details were revealed last week. The Presdient describes precision medicine as “delivering the right treatments, at the right time, every…
Below are excerpts from a recent Health Affairs paper by Goldman and Philipson (2014): Myth #1: The War on Cancer has been a failure. Survival rates for all cancers increased by almost four years during the period 1988–2000. Myth 2: Detection, Not Treatment, Accounts For Most Of The Survival Gains. During 1988–2000 almost 80 percent of…
The Dartmouth Atlas released a new report describing how end-of-life cancer care is changing over time. Their analysis uses data from a 20 percent sample of all Medicare beneficiaries who died between the ages of 66 and 99 years during 2010, who had cancer diagnosis with a poor prognosis. The authors find that: Deaths in…
The Institute of Medicine (IOM) makes a number of recommendations on how to improve cancer care in their 2013 report. I have listed them all here. For some of these recommendations, I have comments below. The Centers for Medicare & Medicaid Services and other payers should design, implement, and evaluate innovative payment models that incentivize…
Oftentimes, health services research measure access as the distance between a patient and the nearest provider of a given type (e.g., hospital, physician). This issue of access is particularly relevant for individuals with cancer, since cancer care typically requires supervisions from specialist oncologists. In most cases, health services researchers assume that individuals located far from…
In 2008, 2.45 million people were diagnosed with cancer and 1.23 million died because of cancer in the European Union (EU). What is the economic burden of cancer? A paper by Luengo-Fernandez (2013) aims to estimate just this quantity. They find that: Cancer cost the EU €126 billion in 2009…Across the EU, the health-care costs…
The National Cancer Institute (NCI) publishes screeening rates for breast, cervical, and colorectal cancers over the past 25 years. I have reproduced the charts below. I wonder how the USPSTF recommendation in November 2009 that women ages 40 to 49 should not undergo screening unless they are in a high-risk group will affect mammography rates in the most recent…